Stribbling SM, Beach C, Ryan AJ. Orthotopic and metastatic tumour models in preclinical cancer research. Pharmacol Ther. 2024;257:108631.

Article  CAS  PubMed  Google Scholar 

Jeffreys N, Brockman JM, Zhai Y, Ingber DE, Mooney DJ. Mechanical forces amplify TCR mechanotransduction in T cell activation and function. Appl Phys Rev. 2024;11:011304.

Article  CAS  PubMed  Google Scholar 

Martinez M, Moon EK. CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front Immunol. 2019;10:128.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krishna S, Lowery FJ, Copeland AR, Bahadiroglu E, Mukherjee R, Jia L, et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science. 2020;370:1328–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baulu E, Gardet C, Chuvin N, Depil S. TCR-engineered T cell therapy in solid tumors: state of the art and perspectives. Sci Adv. 2023;9:eadf3700.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Q, Zhong X, Li J, Hu R, Yi J, Sun J, et al. Exosomal ncRNAs: multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma. Biomed Pharmacother. 2024;173:116409.

Article  CAS  PubMed  Google Scholar 

Dong MB, Tang K, Zhou X, Zhou JJ, Chen S. Tumor immunology CRISPR screening: present, past, and future. Trends Cancer. 2022;8:210–25.

Article  CAS  PubMed  Google Scholar 

Quintero-Ruiz N, de Oliveira W, L, Esteca MV, Granato DC, Simabuco FM. Uncovering the bookshelves of CRISPR-based libraries: advances and applications in cancer studies. Crit Rev Oncol Hematol. 2024;196:104287.

Article  PubMed  Google Scholar 

Liu D, Zhao X, Tang A, Xu X, Liu S, Zha L, et al. CRISPR screen in mechanism and target discovery for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2020;1874:188378.

Article  CAS  PubMed  Google Scholar 

Reardon S. First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment. Nature. 2024. https://doi.org/10.1038/d41586-024-00673-w.

Article  PubMed  Google Scholar 

Creelan BC, Wang C, Teer JK, Toloza EM, Yao J, Kim S, et al. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nat Med. 2021;27:1410–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carnevale J, Shifrut E, Kale N, Nyberg WA, Blaeschke F, Chen YY, et al. RASA2 ablation in T cells boosts antigen sensitivity and long-term function. Nature. 2022;609:174–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan C-X, Zhu Z. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022;41:119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nathan P, Hassel JC, Rutkowski P, Baurain J-F, Butler MO, Schlaak M, et al. Overall survival benefit with tebentafusp in metastatic uveal melanoma. N Engl J Med. 2021;385:1196–206.

Article  CAS  PubMed  Google Scholar 

Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q, et al. Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL. Nature. 2022;609:369–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foy SP, Jacoby K, Bota DA, Hunter T, Pan Z, Stawiski E, et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature. 2023;615:687–96.

Article  CAS  PubMed  Google Scholar 

Xu X, Sun Q, Liang X, Chen Z, Zhang X, Zhou X, et al. Mechanisms of relapse after CD19 CAR T-cell therapy for acute lymphoblastic leukemia and its prevention and treatment strategies. Front Immunol. 2019;10:2664.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Z, Condomines M, van der Stegen SJC, Perna F, Kloss CC, Gunset G, et al. Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells. Cancer Cell. 2015;28:415–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamieh M, Dobrin A, Cabriolu A, van der Stegen SJC, Giavridis T, Mansilla-Soto J, et al. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature. 2019;568:112–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tao R, Han X, Bai X, Yu J, Ma Y, Chen W, et al. Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR/Cas9 gene editing technology. Front Immunol. 2024;15:1354825.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alshaer W, Zureigat H, Al Karaki A, Al-Kadash A, Gharaibeh L, Hatmal MM, et al. siRNA: mechanism of action, challenges, and therapeutic approaches. Eur J Pharmacol. 2021;905:174178.

Article  CAS  PubMed  Google Scholar 

Rao DD, Vorhies JS, Senzer N, Nemunaitis J. siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev. 2009;61:746–59.

Article  CAS  PubMed  Google Scholar 

Chan Y-T, Lu Y, Wu J, Zhang C, Tan H-Y, Bian Z-X, et al. CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives. Theranostics. 2022;12:3329–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu Z, Ni K, Wang Y, Zhou Y, Li Y, Yan J, et al. An in-library ligation strategy and its application in CRISPR/Cas9 screening of high-order gRNA combinations. Nucleic Acids Res. 2022;50:6575–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidt R, Steinhart Z, Layeghi M, Freimer JW, Bueno R, Nguyen VQ, et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 2022;375:eabj4008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roth TL, Li PJ, Blaeschke F, Nies JF, Apathy R, Mowery C, et al. Pooled knockin targeting for genome engineering of cellular immunotherapies. Cell. 2020;181:728-744.e21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Legut M, Gajic Z, Guarino M, Daniloski Z, Rahman JA, Xue X, et al. A genome-scale screen for synthetic drivers of T cell proliferation. Nature. 2022;603:728–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng J, Lin G, Wang T, Wang Y, Guo W, Liao J, et al. Massively parallel CRISPR-based genetic perturbation screening at single-cell resolution. Adv Sci. 2023;10: e2204484.

Article  Google Scholar 

Meyers S, Demeyer S, Cools J. CRISPR screening in hematology research: from bulk to single-cell level. J Hematol Oncol. 2023;16:107.

Article  PubMed  PubMed Central